| | | Deep dive into the topic of innovation and tech in the November issue of Swedish Chamber Insights! | | With Swedish Chamber Insights, we will bring you deep-dive exclusive interviews, highlight our members' strategies in the Insight features, and present opportunities to connect with our members and create relationships within our business community through the Get to Know series. We are happy to offer our community an unparalleled glimpse into the activities within and around the Swedish Chamber of Commerce’s network. We hope you will take this chance to interact, connect, unveil business opportunities, learn from each other, share new ideas – and, as the title indicates – gain insights. This month, we delve into innovation and tech, focusing on AI, sustainability, and leadership, alongside the latest trends in healthcare and business transformation. We hope you enjoy the read! | | | Exclusive Interview: Martin Svensson, Managing Director at AI Sweden, shares his insights on the current landscape of AI in Sweden, emphasizing the need for bold leadership, and offers six key leadership principles for AI success. | | | | | Innovation & Tech Insight: Gain insight into how AstraZeneca leverages AI and data science to continuously push the boundaries of healthcare innovation, shaping a future where healthcare is faster, more affordable, and highly effective. | | | | | | | | Strengthening Sweden's AI Leadership for a Competitive Future - Managing Director at AI Sweden, Martin Svensson | | In the rapidly evolving world of artificial intelligence (AI), AI Sweden stands at the forefront of Sweden’s AI transformation. As the National Center for Applied AI, AI Sweden is dedicated to enabling the adoption of AI across the private and public sectors by partnering with over 140 organizations. In this interview with the Swedish Chamber Martin Svensson, Managing Director at AI Sweden, shares his insights how his organization is driving AI innovation, fostering collaboration, and preparing Sweden for a competitive future in the AI age. | | | | Unlike academia-based research bodies, AI Sweden’s emphasis is on applied research and hands-on collaboration with companies. "We are working closely with the companies and organizations that are to using, innovating, and building AI," Martin explains.
By building partnerships with a diverse range of 140 organizations, including private companies, public sector entities, and research institutes, AI Sweden acts as a collaborative platform that accelerates AI adoption. "Our role is to facilitate collaboration," Martin demonstrates. “By gathering parts of the Swedish AI ecosystem, we can collectively drive these questions forward.”
AI Sweden’s applied research teams are deeply involved in developing language models and AI solutions tailored to organizations’ unique needs. Beyond AI development, the organization plays a significant role in understanding leadership and organizational strategies necessary for AI success. | | | | | | | | AstraZeneca and the future of AI in medicine research | | At AstraZeneca, we harness artificial intelligence (AI) and advanced data analytics to shape the future of healthcare. By integrating these technologies into our research and development processes, we accelerate the discovery of new medicines and improve patient care for conditions including cancer, cardiovascular diseases, kidney disorders, respiratory and metabolic diseases, and rare conditions.
AI enables us to derive insights from vast amounts of medical data at an unprecedented pace. This allows us to understand diseases more quickly, identify new molecules with therapeutic potential faster, and develop treatment options that are better aligned with the needs of patients worldwide. From analyzing genetic data to improving image analysis and optimizing clinical trials, AI enables us to translate new insights into effective therapies more quickly.
| | | | | | | Get to Know: IPscreener
Hear from Linus Wretblad, CEO of IPscreener, as he discusses how the company’s AI-powered platform uncovers unexpected insights in innovation.
Linus shares how IPscreener simplifies patent data analysis, helping businesses identify existing solutions, track R&D trends, and avoid reinventing the wheel. He also explores how this real-time intelligence empowers companies to make informed decisions early in development, accelerating innovation and minimizing risks associated with overlooked intellectual property. | | Linus Wretblad CEO & Founder | | | | | | | Want to be featured in upcoming Swedish Chamber Insights? | | As always, we are happy to receive your feedback and ideas. Welcome to reach out to communication@swedishchamber.nl with your input, questions and thoughts about our upcoming Swedish Chamber Insights, and information on how you can present your company in the upcoming issues in 2024! | | | | | | | |